
SiNtx Technologies, Inc. Common Stock
SINT
SINT: SINTX Technologies Inc is a commercial biomaterial company engaged in using its silicon nitride technology platform to develop, manufacture, and sell a range of medical devices. The company derives product revenue primarily from the manufacture and sale of spinal fusion products used in the treatment of spine disorders. It produces silicon nitride for use in commercial products and product candidates in the forms of Solid Silicon Nitride, Porous Silicon Nitride, and Silicon Nitride Powder, among others. It is also engaged in developing wear-and corrosion-resistant implant components for hip and knee arthroplasty.
moreShow SINT Financials
Recent trades of SINT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SINT's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Antibacterial biomedical implants and associated materials, apparatus, and methods Aug. 29, 2023
-
Patent Title: Antifungal composites and methods thereof Jun. 13, 2023
-
Patent Title: Antipathogenic devices and methods thereof Feb. 28, 2023
-
Patent Title: Antipathogenic devices and methods thereof Dec. 07, 2021
-
Patent Title: Antibacterial biomedical implants and associated materials, apparatus, and methods Oct. 20, 2020
Federal grants, loans, and purchases
Followers on SINT's company Twitter account
Number of mentions of SINT in WallStreetBets Daily Discussion
Recent insights relating to SINT
Recent picks made for SINT stock on CNBC
ETFs with the largest estimated holdings in SINT
Flights by private jets registered to SINT